investor harm

Class action lawsuit filed against Paysafe alleging failure to disclose high-risk client exposure, understated credit reserves, and merchant category issues.

Class action filed against Ultragenyx ($RARE) alleging misrepresented setrusumab trial data. Investors purchasing August 2023-December 2025 may recover damages.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales driven by inventory accumulation rather than genuine demand.

Class action lawsuit filed against AMC over alleged securities violations regarding APE preferred equity units and distribution rights.

Class action lawsuit filed against $PLUG alleging false statements about DOE loan availability and hydrogen facility construction capability.

Bath & Body Works faces class action lawsuit alleging executives made false statements about growth strategy effectiveness. Lead plaintiff deadline is March 13, 2026.

Class action filed against $BSX alleging executives misrepresented U.S. electrophysiology segment sustainability. Claims executives concealed adverse trends, competitive pressures, regulatory challenges.

Class action filed against Lakeland Industries alleging executives misrepresented Pacific Helmets and Jolly performance while hiding operational issues including shipping delays and tariff pressures.

Class action filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, affecting investors from July-October 2025.

Snowflake faces class action alleging company concealed material information about product changes harming revenue while making misleading positive statements through early 2024.

Mereo BioPharma faces class action over failed Phase 3 trials and alleged misleading statements. Investor deadline April 6, 2026.

Class action filed against $SDM alleging market manipulation, social media fraud, and insider share dumping. Investors who bought between May-September 2025 eligible to join.

Class action filed against Enphase Energy alleging inventory misstatement and 25D Tax Credit disclosure failures. Lead plaintiff deadline April 20, 2026.

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy. Covers investors from Feb 2022 to Jan 2026; lead plaintiff deadline April 14.

NuScale Power faces class action lawsuit alleging it misrepresented partner ENTRA1's nuclear experience and failed to disclose material partnership risks to investors.

Class action lawsuit filed against Kyndryl Holdings alleging false financial statements and internal control failures from August 2024 to February 2026. Lead plaintiff deadline April 13, 2026.

Class action lawsuit filed against BellRing Brands alleges materially false sales statements; claims growth driven by inventory accumulation, not genuine demand.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facility prospects between January and November 2025.

Lakeland Industries faces class action over alleged misstatements on business operations, tariffs, and financial guidance from December 2023 to December 2025.

Class action lawsuit filed against $UGXY alleging securities fraud over misleading setrusumab trial data and OI patient safety disclosures.